Abstract
There are many similarities in molecular mechanisms of neuronal cell death observed in ischemic stroke and Alzheimers disease. From point of organelle damage, we introduced molecular events seen in ischemic stroke, and compared the findings with that observed in Alzheimers disease. In the brain after ischemia, transmembrane potential and ion gradient are disturbed at very early stage. Several drugs are aimed to minimize this change, some of which were effective in experimental models. Calcium blocker and glutamate antagonist were also effective for Alzheimers disease. As for mitochondrial and endoplasmic reticulum damage, both disorders share common pathological findings such as proapoptotic signals activation. However, there are some molecules which are neuroprotective in Alzheimers disease but pro-apoptotic in ischemic neurons. We need to be so careful for judging the significance of a phenomenon obtained by an experiment. Lysosome, called as suicide bag, play important roles both in the brain of ischemic stroke and Alzheimers disease. Leak of lysosomal enzymes influence, at least partially, the fate of neurons under pathological conditions in both disorders.
Keywords: Alzheimer's disease, cell death, ischemia, organelle
Current Alzheimer Research
Title: Molecular Mechanisms of Ischemic Neuronal Cell Death - With Relevance to Alzheimers Disease
Volume: 3 Issue: 4
Author(s): Takeshi Hayashi, Mikio Shoji and Koji Abe
Affiliation:
Keywords: Alzheimer's disease, cell death, ischemia, organelle
Abstract: There are many similarities in molecular mechanisms of neuronal cell death observed in ischemic stroke and Alzheimers disease. From point of organelle damage, we introduced molecular events seen in ischemic stroke, and compared the findings with that observed in Alzheimers disease. In the brain after ischemia, transmembrane potential and ion gradient are disturbed at very early stage. Several drugs are aimed to minimize this change, some of which were effective in experimental models. Calcium blocker and glutamate antagonist were also effective for Alzheimers disease. As for mitochondrial and endoplasmic reticulum damage, both disorders share common pathological findings such as proapoptotic signals activation. However, there are some molecules which are neuroprotective in Alzheimers disease but pro-apoptotic in ischemic neurons. We need to be so careful for judging the significance of a phenomenon obtained by an experiment. Lysosome, called as suicide bag, play important roles both in the brain of ischemic stroke and Alzheimers disease. Leak of lysosomal enzymes influence, at least partially, the fate of neurons under pathological conditions in both disorders.
Export Options
About this article
Cite this article as:
Hayashi Takeshi, Shoji Mikio and Abe Koji, Molecular Mechanisms of Ischemic Neuronal Cell Death - With Relevance to Alzheimers Disease, Current Alzheimer Research 2006; 3(4) . https://dx.doi.org/10.2174/156720506778249498
DOI https://dx.doi.org/10.2174/156720506778249498 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Current Strategies and Novel Drug Approaches for Alzheimer Disease
CNS & Neurological Disorders - Drug Targets Effects of Transition Metals in the Conversion Mechanism of Prion Protein and in the Pathogenesis of Prion Diseases
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Aging - How Lifestyle Changes Could Prove to be an Effective Medicine for the Aging Cardiovascular System
Current Cardiology Reviews The Kynurenine Pathway in the Acute and Chronic Phases of Cerebral Ischemia
Current Pharmaceutical Design New Pharmacological Approaches in Infants with Hypoxic-Ischemic Encephalopathy
Current Pharmaceutical Design Accelerated Fibrillation of α-Synuclein Induced by the Combined Action of Macromolecular Crowding and Factors Inducing Partial Folding
Current Alzheimer Research Unmasking Sex-Based Disparity in Neuronal Metabolism
Current Pharmaceutical Design Involvement of Coagulation and Hemostasis in Inflammatory Bowel Diseases
Current Vascular Pharmacology Inflammation and Chronic Oxidative Stress in Radiation-Induced Late Normal Tissue Injury: Therapeutic Implications
Current Medicinal Chemistry Bottom-Up Proteomics
Current Analytical Chemistry Prevention and Treatment of Alzheimer Disease and Aging: Antioxidants
Mini-Reviews in Medicinal Chemistry Neuropsychiatric and Cognitive Symptoms in Spinocerebellar Ataxia: Relationship to Neuropathological Differences
Current Psychiatry Reviews Subject Index To Volume 8
Protein & Peptide Letters Chronic Stress Impacts on Olfactory System
CNS & Neurological Disorders - Drug Targets Virgin Olive Oil and Hypertension
Current Vascular Pharmacology Therapeutic Effects of Rivastigmine and Alfa-Lipoic Acid Combination in the Charles Bonnet Syndrome: Electroencephalography Correlates
Current Clinical Pharmacology Mass Spectrometric Imaging of the Nervous System
Current Pharmaceutical Design Genetic Surgery - A Right Strategy to Attack Cancer
Current Gene Therapy Familial Alzheimers Disease Mutations in Presenilin 1 Do Not Alter Levels of the Secreted Amyloid-β Protein Precursor Generated by β-Secretase Cleavage
Current Alzheimer Research 4-Acetamidobenzaldehyde Derivatives as Biological Active Candidates; Synthesis, Anti-oxidant, Anti-Alzheimer and DNA Binding Studies
Letters in Drug Design & Discovery